Display Settings:

Format

Send to:

Choose Destination
    Nat Neurosci. 2006 Dec;9(12):1534-40. Epub 2006 Nov 19.

    Dynorphin A activates bradykinin receptors to maintain neuropathic pain.

    Source

    Department of Pharmacology, University of Arizona Health Sciences Center, 1501 N. Campbell Ave., Tucson, Arizona 85724, USA. lai@u.arizona.edu

    Abstract

    Dynorphin A is an endogenous opioid peptide that produces non-opioid receptor-mediated neural excitation. Here we demonstrate that dynorphin induces calcium influx via voltage-sensitive calcium channels in sensory neurons by activating bradykinin receptors. This action of dynorphin at bradykinin receptors is distinct from the primary signaling pathway activated by bradykinin and underlies the hyperalgesia produced by pharmacological administration of dynorphin by the spinal route in rats and mice. Blockade of spinal B1 or B2 receptor also reverses persistent neuropathic pain but only when there is sustained elevation of endogenous spinal dynorphin, which is required for maintenance of neuropathic pain. These data reveal a mechanism for endogenous dynorphin to promote pain through its agonist action at bradykinin receptors and suggest new avenues for therapeutic intervention.

    PMID:
    17115041
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk